-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Initiates Coverage On Integra Lifesciences with Market Perform Rating, Announces Price Target of $19

Benzinga·07/09/2026 14:56:25
Listen to the news
BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Market Perform rating and announces Price Target of $19.